Mark Mullikin Email & Phone Number
Chief Financial Officer @ Ensem Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Mullikin Location
- Boston, MA, US
Mark Mullikin Work
- Chief Financial Officer @ (November 2025 - Present)
- Managing Partner @ (February 2025 - Present)
- Chief Financial Officer @ (February 2025 - Present)
- Chief Financial Officer @ (February 2021 - February 2025)
- Vice President, Finance and Investor Relations @ (April 2019 - December 2020)
- Senior Director, Finance and Investor Relations @ (January 2016 - January 2019)
- Director, Health Economics and Strategic Pricing @ (January 2014 - January 2015)
- Director, Financial and Strategic Planning @ (January 2009 - January 2013)
- Equity Analyst - Healthcare @ (January 2008 - January 2009)
- Vice President, Senior Research Analyst - Healthcare @ (January 2002 - January 2008)
- Engagement Manager @ (January 2002 - January 2002)
- Engagement Manager @ (January 1999 - January 2001)
- Investment Banking Summer Associate @ (January 1998 - January 1998)
- Business Analyst @ (January 1995 - January 1997)
Mark Mullikin Education
- MIT Sloan School of Management
MBA (Finance & Accounting)
- University of Chicago
BA (Economics)
- UPF Barcelona School of Management
Postgraduate Diploma (Pharmacoeconomics/Pharmaceutical Economics)
Mark Mullikin Skills
- Analytics
- Biotechnology
- Budgeting
- Business Development
- Capital Budgeting
- Capital Markets
- Capital Raising
- Competitive Analysis
- Corporate FP&A
- Due Diligence
- Early-stage Startups
- Equity Research
- Finance
- Financial Analysis
- Financial Forecasting
- Financial Modeling
- Financial Planning
- Financial Reporting
- Investment Management
- Investor Relations
- Lifesciences
- Market Analysis
- Marketing Strategy
- Mergers & Acquisitions
- Pharmaceutical Industry
- Portfolio Management
- Strategic Planning
- Strategy
- Valuation
- Project Management
- Investments
- Mergers and Acquisitions
Mark Mullikin Summary
- Mark Mullikin, based in Boston, MA, US, is currently a Chief Financial Officer at Ensem Therapeutics. Mark Mullikin brings experience from previous roles at Value Creation Partners, Vedanta Biosciences, Inc. and Editas Medicine. Mark Mullikin holds a MBA in Finance & Accounting @ MIT Sloan School of Management. With a robust skill set that includes Analytics, Biotechnology, Budgeting, Business Development, Capital Budgeting and more. Mark Mullikin has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Mullikin?
Find contact details for 700 million professionals.
Others Named Mark Mullikin
Mark Mullikin
Regional Manager
Roseville, CA, US
Mark Mullikin
Chief Financial Officer
Boston, MA, US
Top Ensem Therapeutics Employees
Jeff Kutok
Chief Scientific Officer
Waltham, MA, US
Raj Nagaraja
SVP and Head of DMPK and Program Management
Waltham, MA, US
Tao Liu
Senior Vice President and Head of Chemistry
Boston, MA, US
Eric Simone
Vice President, Head of Technical Operations
United States
Robbie Chen
Sr. Director of Process Chemistry
Waltham, MA, US
Rob Koncar
Senior Pricipal Scientist
Boston, MA, US
Shengfang Jin
President and CEO
Boston, MA, US
Janaki Parameswaran
VP, Head of Clinical Development
United States
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co